Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2025)

Historic Non-Current Assets for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $8.7 million.

  • Camp4 Therapeutics' Non-Current Assets fell 4522.7% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.9 million, marking a year-over-year change of. This contributed to the annual value of $11.9 million for FY2024, which is 2015.0% down from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Non-Current Assets is $8.7 million, which was down 4522.7% from $10.2 million recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' Non-Current Assets peaked at $15.9 million during Q3 2024, and registered a low of $8.7 million during Q3 2025.
  • Moreover, its 3-year median value for Non-Current Assets was $11.5 million (2024), whereas its average is $12.1 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first crashed by 2015.0% in 2024, then crashed by 4522.7% in 2025.
  • Quarter analysis of 3 years shows Camp4 Therapeutics' Non-Current Assets stood at $14.9 million in 2023, then fell by 20.15% to $11.9 million in 2024, then decreased by 27.15% to $8.7 million in 2025.
  • Its Non-Current Assets was $8.7 million in Q3 2025, compared to $10.2 million in Q2 2025 and $11.1 million in Q1 2025.